Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246. | Br J Cancer | 2022 | 36138076 | PubTator, text mining | PubMed |
| A human STAT3 gain-of-function variant confers T cell dysregulation without predominant Treg dysfunction in mice. | JCI Insight | 2022 | 36136607 | PubTator, text mining | PubMed |
| IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike. | Front Immunol | 2022 | 36131918 | PubTator, text mining | PubMed |
| Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis. | Cell Rep | 2022 | 36130508 | PubTator, text mining | PubMed |
| CTLs Get SMAD When Pathogens Tell Them Where to Go. | J Immunol | 2022 | 36130123 | PubTator, text mining | PubMed |
| Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD. | Respir Res | 2022 | 36127695 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma. | Cell Discov | 2022 | 36127333 | PubTator, text mining | PubMed |
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors. | J Exp Clin Cancer Res | 2022 | 36123711 | PubTator, text mining | PubMed |
| Saliva as a propitious diagnostic biofluid, biomarker, and bodies first line of defense against COVID-19: A review. | J Family Med Prim Care | 2022 | 36119338 | PubTator, text mining | PubMed |
| Renal manifestations of COVID 19 in children. | J Family Med Prim Care | 2022 | 36119332 | PubTator, text mining | PubMed |
| Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination. | Front Immunol | 2022 | 36119105 | PubTator, text mining | PubMed |
| Cellular senescence is a key mediator of lung aging and susceptibility to infection. | Front Immunol | 2022 | 36119079 | PubTator, text mining | PubMed |
| Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19. | Struct Chem | 2022 | 36118173 | PubTator, text mining | PubMed |
| Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. | Clin Cancer Res | 2022 | 36112544 | PubTator, text mining | PubMed |
| A shift in lung macrophage composition is associated with COVID-19 severity and recovery. | Sci Transl Med | 2022 | 36103512 | PubTator, text mining | PubMed |
| Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia. | J Clin Invest | 2022 | 36099049 | PubTator, text mining | PubMed |
| Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. | Nat Med | 2022 | 36097221 | PubTator, text mining | PubMed |
| Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature. | Front Genet | 2022 | 36092924 | PubTator, text mining | PubMed |
| Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer. | Front Immunol | 2022 | 36090985 | PubTator, text mining | PubMed |
| Integrative and comparative single-cell analysis reveals transcriptomic difference between human tumefactive demyelinating lesion and glioma. | Commun Biol | 2022 | 36085357 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=54